Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 4,488 shares at $44.19 ($198K) on 2024-09-16, disclosed to the SEC on 2024-09-18.
Scheduled sale ($198k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.19 | 2,244 | $99K | 50.0% |
| 2 | $44.19 | 2,244 | $99K | 50.0% |
| Total | $44.19 avg | 4,488 | $198K | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $425K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |